D. Boral Capital Downgrades Artelo Biosciences, Inc. (ARTL) to Hold
Tweet Send to a Friend
D. Boral Capital analyst Jason Kolbert downgraded Artelo Biosciences, Inc. (NASDAQ: ARTL) from Buy to Hold.The analyst comments "We are ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
